if 15.72, last high breaks, i see new leg coming
i see uptrend continous break of 1.8 important
short term target on chart see some MOMO until FDA news coming out 07/18/2018 Phase 2 commencement of Part 2 of Phase 2/3 trial announced January 4, 2018. Interim data due at ISTH July 18, 2018. Final data due at ASH 2018. potential gapper candidate
slower stock, i like the set up no investment advice Im in this @ 2.04
07/28/2018 PDUFA date July 28, 2018. Advisory Committee Meeting May 22, 2018 voted against approval.
watch for breakout of pennant and retest before entering
good news Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company, today announced that its MyoPro myoelectric arm orthosis (powered brace) is now available to adolescent patients with paralyzed or weakened arms. MyoPro is the only lightweight wearable device on the market that can help restore substantial functionality in...
might go lower to test fib retracement
next leg up has started, see much more potential mid term
long sideways movement good accumulation i like this company Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa.
handle has been finished. lets see
sector booming broke double top good vol
energy sector booming i like the set up
surpassed downtrend trendline RSI has been bullish last weeks i see further upside move
moving in a channel with building higher lows future cash flow value 6.67 USD